ZAKBRILSA
Live / Applied — Suspended — suspension letter mailed (as of 12 Sept 2026)
What this means for you
Not registered yet, but its 13 Aug 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50049223
- Mark type
- Stylized text
- Filed
- 13 Aug 2026
- Attorney of record
- Lisa M. Dellamura
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, retinal, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
Owner
- Merck Sharp & Dohme B.V., Haarlem, NL
Prosecution history
- 12 Sept 2026 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 12 Sept 2026 — LETTER OF SUSPENSION E-MAILED
- 12 Sept 2026 — SUSPENSION LETTER WRITTEN
- 12 Sept 2026 — ASSIGNED TO EXAMINER
- 13 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 13 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 13 Aug 2026 — NEW APPLICATION ENTERED